Telemedicine Home-based Management in Patients With CHF and Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

August 18, 2022

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Chronic Heart FailureDiabetes Mellitus
Interventions
OTHER

Teleassistance

Support the nursing case manager through a structured teleconsultation program (telephone and videoconference support at least once a week)

OTHER

Teleconsultation

Cardiological and Diabetological teleconsultation at the beginning of the program and in case of need during the program.

OTHER

Telerehabilitation

Support from a physiotherapist (if needed)

OTHER

Telemonitoring

Telemonitoring of patient vital signs (eg single electrocardiographic trace) and delay steps

OTHER

mHealth

The support of an App for recording and monitoring parameters: delay treatment, clinical parameters such as glycemia, blood pressure, HR, symptoms, etc.

OTHER

telepsycology

Psychological support (if necessary)

OTHER

Quality of life

Minnesota LIVING WITH HEART FAILURE® Questionnaire (MLHFQ), Short Form Survey (SF-12) Questionnaire and Diabetes Quality of Life (DQoL) questionnaire

OTHER

Biochemistry evaluation

Glycemia, glycated haemoglobin, total cholesterol, HDL and LDL, triglycerides, creatinine, BUN, creatinine clearance, BNP

OTHER

Clinical evaluation

6-minute-walking test, IMC, NYHA class, Ejection fraction

OTHER

State of health of the patient

Severity Index and Comordbidity index

Trial Locations (3)

25065

Istituti Clinici Scientifici Maugeri, Lumezzane

Unknown

Azienda Ospedaliera Bolognini di Seriate Bergamo, Seriate

Papa Giovanni XXIII Hospital, Bergamo

All Listed Sponsors
collaborator

Azienda Ospedaliera Bolognini di Seriate Bergamo

OTHER

collaborator

Papa Giovanni XXIII Hospital

OTHER

lead

Istituti Clinici Scientifici Maugeri SpA

OTHER